Clinical Trials

Showing trials with last updates posted in 2021.

NCT01816984 | COMPLETED | PHASE1/PHASE2
12 participants

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-10-05
Start Date:
2013-05-31
Completion:
2018-04-30
Conditions
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • Recurrent Metastatic Squamous Neck Cancer With Occult Primary
  • Recurrent Salivary Gland Cancer
  • Recurrent Squamous Cell Carcinoma of the Hypopharynx
  • Recurrent Squamous Cell Carcinoma of the Larynx
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Recurrent Squamous Cell Carcinoma of the Nasopharynx
  • Recurrent Squamous Cell Carcinoma of the Oropharynx
  • Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
  • Recurrent Verrucous Carcinoma of the Larynx
  • Recurrent Verrucous Carcinoma of the Oral Cavity
  • Salivary Gland Squamous Cell Carcinoma
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • Stage IV Squamous Cell Carcinoma of the Nasopharynx
  • Stage IVA Salivary Gland Cancer
  • Stage IVA Squamous Cell Carcinoma of the Larynx
  • Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Stage IVA Squamous Cell Carcinoma of the Oropharynx
  • Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
  • Stage IVA Verrucous Carcinoma of the Larynx
  • Stage IVA Verrucous Carcinoma of the Oral Cavity
  • Stage IVB Salivary Gland Cancer
  • Stage IVB Squamous Cell Carcinoma of the Larynx
  • Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Stage IVB Squamous Cell Carcinoma of the Oropharynx
  • Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
  • Stage IVB Verrucous Carcinoma of the Larynx
  • Stage IVB Verrucous Carcinoma of the Oral Cavity
  • Stage IVC Salivary Gland Cancer
  • Stage IVC Squamous Cell Carcinoma of the Larynx
  • Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Stage IVC Squamous Cell Carcinoma of the Oropharynx
  • Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
  • Stage IVC Verrucous Carcinoma of the Larynx
  • Stage IVC Verrucous Carcinoma of the Oral Cavity
  • Tongue Cancer
Interventions
  • DRUG
  • BIOLOGICAL
NCT05066958 | UNKNOWN | PHASE1/PHASE2
20 participants

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Study Type:
INTERVENTIONAL
Last Updated:
2021-10-04
Start Date:
2021-09-16
Completion:
2022-09-01
Conditions
  • Acute Myeloid Leukemia
  • High Risk Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia, in Relapse
  • High Risk Acute Lymphoblastic Leukemia
  • Acute Biphenotypic Leukemia in Relapse
  • Non-hodgkin Lymphoma
  • Myelodysplastic Syndromes
Interventions
  • BIOLOGICAL
No Results Yet
NCT05066893 | UNKNOWN | NA
32 participants

Pediatric Boot Camp Program

Study Type:
INTERVENTIONAL
Last Updated:
2021-10-04
Start Date:
2020-11-05
Completion:
2023-11-05
Conditions
  • Type 1 Diabetes
  • Children, Only
Interventions
  • OTHER
No Results Yet
NCT05066867 | UNKNOWN
100 participants

LMWH Compliance in Pregnancy

Study Type:
OBSERVATIONAL
Last Updated:
2021-10-04
Start Date:
2021-01-01
Completion:
2022-01-01
Conditions
  • Venous Thromboembolism
  • Antenatal Deep Vein Thrombosis
Interventions
  • OTHER
No Results Yet
NCT05066763 | RECRUITING
1000000 participants

Parkinson's Foundation Surveys

Study Type:
OBSERVATIONAL
Last Updated:
2021-10-04
Start Date:
2021-04-02
Completion:
2030-12-31
Conditions
  • Parkinson Disease
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page